Cancer Research Annual Meeting 2010  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thelwall, P. E.
Right arrow Articles by Gamcsik, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thelwall, P. E.
Right arrow Articles by Gamcsik, M. P.
[Cancer Research 65, 10149-10153, November 15, 2005]
© 2005 American Association for Cancer Research


Priority Reports

Noninvasive In vivo Detection of Glutathione Metabolism in Tumors

Peter E. Thelwall1, Avner Y. Yemin1, Theresa L. Gillian3, Nicholas E. Simpson2, Mohit S. Kasibhatla5, Zahid N. Rabbani5, Jeffrey M. Macdonald3, Stephen J. Blackband1,6 and Michael P. Gamcsik4

1 Department of Neuroscience, McKnight Brain Institute, and 2 Department of Medicine, University of Florida, Gainesville, Florida; 3 Department of Biomedical Engineering, University of North Carolina, Chapel Hill, North Carolina; Departments of 4 Medicine, Division of Medical Oncology, and 5 Radiation Oncology, Duke University Medical Center, Durham, North Carolina; and 6 National High Magnetic Field Laboratory, Tallahassee, Florida

Requests for reprints: Michael P. Gamcsik, Duke University Medical Center, Box 2638, MSRB 395, Research Drive, Durham, NC 27710. Phone: 919-681-2244; Fax: 919-668-3925; E-mail: michael.gamcsik{at}duke.edu.

Magnetic resonance spectroscopic imaging has been used to follow glutathione metabolism and evaluate glutathione heterogeneity in intact tumor tissue. Stable isotope-labeled glutathione was detected in s.c. implanted fibrosarcoma tumors in anesthetized rats following infusion of [2-13C]glycine. Using 1H-decoupled 13C magnetic resonance spectroscopy, the appearance of [2-13C]glycine at 42.4 ppm and the subsequent incorporation of this isotope label into the glycyl residue of glutathione at 44.2 ppm can be detected. The identity and relative concentrations of labeled metabolites observed in the in vivo spectrum were confirmed in studies of tissue extracts. The high level of isotopic enrichment and the concentration of glutathione in tumor tissue allow for collection of spatially localized spectra using 13C chemical shift imaging methods. These data provide the first direct images of glutathione in intact tumor tissue and show metabolic heterogeneity. This method may lead to the ability to monitor changes in tumor tissue redox state that may ultimately affect diagnosis, monitoring, and treatment.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.